Earnings Call · Q4 FY2022·2023-02-21

Q4 22EPS -18.87%·Rev n/aQ3 22EPS -21.43%·Rev n/aQ2 22EPS -43.92%·Rev n/aQ1 22EPS -7.23%·Rev n/a⚠ consensus missing

PTC THERAPEUTICS, INC. PTCT

Kylie O'Keefe — Investor Relations

Stuart Peltz — Chief Executive Officer

Matthew Klein — Chief Operating Officer

Eric Pauwels — Chief Business Officer

Emily Hill — Chief Financial Officer

−1.1%1d on move date−1.0% vs SPY3d−3.3%5d−2.3%

Research tier

Behavioral profile computed for 5 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more PTCT calls or request research access.

More PTCT calls Browse calls Request research access